1675 related articles for article (PubMed ID: 17569066)
1. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.
Kwong LK; Neumann M; Sampathu DM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2007 Jul; 114(1):63-70. PubMed ID: 17492294
[TBL] [Abstract][Full Text] [Related]
3. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss.
Kobayashi Z; Tsuchiya K; Arai T; Yokota O; Yoshida M; Shimomura Y; Kondo H; Haga C; Asaoka T; Onaya M; Ishizu H; Akiyama H; Mizusawa H
J Neurol Sci; 2010 Nov; 298(1-2):70-7. PubMed ID: 20810131
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
[TBL] [Abstract][Full Text] [Related]
6. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
[TBL] [Abstract][Full Text] [Related]
7. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
[TBL] [Abstract][Full Text] [Related]
8. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
10. A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration.
Nakamura M; Bieniek KF; Lin WL; Graff-Radford NR; Murray ME; Castanedes-Casey M; Desaro P; Baker MC; Rutherford NJ; Robertson J; Rademakers R; Dickson DW; Boylan KB
Acta Neuropathol; 2015 Jul; 130(1):145-57. PubMed ID: 25917047
[TBL] [Abstract][Full Text] [Related]
11. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
[TBL] [Abstract][Full Text] [Related]
12. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
13. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.
Geser F; Brandmeir NJ; Kwong LK; Martinez-Lage M; Elman L; McCluskey L; Xie SX; Lee VM; Trojanowski JQ
Arch Neurol; 2008 May; 65(5):636-41. PubMed ID: 18474740
[TBL] [Abstract][Full Text] [Related]
14. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease.
Katsuse O; Dickson DW
Alzheimer Dis Assoc Disord; 2005; 19 Suppl 1():S37-43. PubMed ID: 16317257
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
[TBL] [Abstract][Full Text] [Related]
17. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations.
Seelaar H; Schelhaas HJ; Azmani A; Küsters B; Rosso S; Majoor-Krakauer D; de Rijk MC; Rizzu P; ten Brummelhuis M; van Doorn PA; Kamphorst W; Willemsen R; van Swieten JC
Brain; 2007 May; 130(Pt 5):1375-85. PubMed ID: 17360763
[TBL] [Abstract][Full Text] [Related]
18. Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease.
Takeda T; Seilhean D; Le Ber I; Millecamps S; Sazdovitch V; Kitagawa K; Uchihara T; Duyckaerts C
J Neuropathol Exp Neurol; 2017 Sep; 76(9):800-812. PubMed ID: 28859337
[TBL] [Abstract][Full Text] [Related]
19. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
20. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
